Explore more publications!
Healthcare Times Denmark
Got News to Share?

Press Releases

Ascendis Pharma to List Ordinary Shares Directly on Nasdaq
Apr. 8, 2026

Ascendis Pharma to List Ordinary Shares Directly on Nasdaq

Indeterminate GlobeNewswire, Inc.
ESO Acquires d2i, Accelerating Emergency Intelligence to Drive Performance and Improve Outcomes across Fire, EMS and Health Systems
Apr. 7, 2026

ESO Acquires d2i, Accelerating Emergency Intelligence to Drive Performance and Improve Outcomes across Fire, EMS and Health Systems

Indeterminate GlobeNewswire, Inc.
Denmark Launches Lawsuit Against Meta Over Child Mental Health Risks
Apr. 1, 2026

Denmark Launches Lawsuit Against Meta Over Child Mental Health Risks

Indeterminate MENAFN
Owner: Sawsan Dababneh

MENAFN

Indeterminate
Owned By Sawsan Dababneh through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Jordan, Amman
Owner Country Jordan

We welcome your feedback!
If you have comments or corrections, let us know.

Clinical Advancements in Gene Therapy for Neurological Diseases Market Outlook 2026–2035
Mar. 31, 2026

Clinical Advancements in Gene Therapy for Neurological Diseases Market Outlook 2026–2035

Neutral EIN Presswire
Dutch Nonprofit Files Lawsuit Against Meta for Child Mental Health Risks
Apr. 1, 2026

Dutch Nonprofit Files Lawsuit Against Meta for Child Mental Health Risks

Indeterminate MENAFN
Owner: Sawsan Dababneh

MENAFN

Indeterminate
Owned By Sawsan Dababneh through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Jordan, Amman
Owner Country Jordan

We welcome your feedback!
If you have comments or corrections, let us know.

Total number of shares and voting rights in Zealand Pharma as of March 31, 2026
Mar. 31, 2026

Total number of shares and voting rights in Zealand Pharma as of March 31, 2026

Indeterminate GlobeNewswire, Inc.
MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer
Mar. 31, 2026

MAIA Biotechnology Reports Overall Survival Exceeding Two Years for Eight Patients in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire, Inc.
Gene and Cell Therapy Spotlighted in Resurrection LA Premiere May 1–7 as San Rocco Therapeutics Advances Toward a Cure
Apr. 10, 2026

Gene and Cell Therapy Spotlighted in Resurrection LA Premiere May 1–7 as San Rocco Therapeutics Advances Toward a Cure

Neutral EIN Presswire
Clinical Study Provides Evidence for the Use of Arla Foods Ingredients’ Lacprodan® IF-3070 in Infant Formula
Mar. 23, 2026

Clinical Study Provides Evidence for the Use of Arla Foods Ingredients’ Lacprodan® IF-3070 in Infant Formula

Indeterminate GlobeNewswire, Inc.
Resolutions from Zealand Pharma's Annual General Meeting 2026
Mar. 26, 2026

Resolutions from Zealand Pharma's Annual General Meeting 2026

Indeterminate GlobeNewswire, Inc.
Older Adults Health Supplements Market to Reach USD 351.1 Billion by 2036 Amid Rising Global Ageing Demand
Mar. 26, 2026

Older Adults Health Supplements Market to Reach USD 351.1 Billion by 2036 Amid Rising Global Ageing Demand

Neutral EIN Presswire
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer
Mar. 17, 2026

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer

Neutral EIN Presswire
VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
Mar. 25, 2026

VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management

Indeterminate GlobeNewswire, Inc.
Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation
Mar. 24, 2026

Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation

Indeterminate GlobeNewswire, Inc.
BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer
Mar. 24, 2026

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer

Indeterminate GlobeNewswire, Inc.
Groundbreaking Danish research project launches to cure Parkinson’s disease
Mar. 23, 2026

Groundbreaking Danish research project launches to cure Parkinson’s disease

Indeterminate GlobeNewswire, Inc.
San Rocco Productions Announces the Los Angeles Premiere of Resurrection starring JOE MANTEGNA
Apr. 10, 2026

San Rocco Productions Announces the Los Angeles Premiere of Resurrection starring JOE MANTEGNA

Neutral EIN Presswire
NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™
Mar. 23, 2026

NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™

Indeterminate GlobeNewswire, Inc.
Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851
Mar. 23, 2026

Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851

Indeterminate GlobeNewswire, Inc.
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Mar. 19, 2026

Zealand Pharma increases its share capital as a result of the exercise of employee warrants

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions